IDEAS home Printed from https://ideas.repec.org/r/oup/indcch/v9y2000i2p315-59.html
   My bibliography  Save this item

Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Yao‐Sheng Liao, 2011. "The effect of human resource management control systems on the relationship between knowledge management strategy and firm performance," International Journal of Manpower, Emerald Group Publishing Limited, vol. 32(5/6), pages 494-511, August.
  2. Havas, Attila, 2010. "Diversity in firms’ innovation strategies and activities: Main findings of interviews and implications in the context of the Hungarian national," MPRA Paper 55852, University Library of Munich, Germany.
  3. Brian Loasby, 2001. "Forum `Knowledge, Evolution and the Theory of the Firm' – Introduction," Journal of Management & Governance, Springer;Accademia Italiana di Economia Aziendale (AIDEA), vol. 5(3), pages 275-285, September.
  4. Laura B. Cardinal & Scott F. Turner & Michael J. Fern & Richard M. Burton, 2011. "Organizing for Product Development Across Technological Environments: Performance Trade-offs and Priorities," Organization Science, INFORMS, vol. 22(4), pages 1000-1025, August.
  5. Sandro Mendonca, 2006. "The Revolution Within: Ict And The Shifting Knowledge Base Of The World'S Largest Companies," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 15(8), pages 777-799.
  6. Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005. "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 14(5), pages 395-415.
  7. Martin Hemmert, 2020. "Does Korean-style management have a future?," Asian Business & Management, Palgrave Macmillan, vol. 19(2), pages 147-170, April.
  8. Becker, Markus C. & Salvatore, Pasquale & Zirpoli, Francesco, 2005. "The impact of virtual simulation tools on problem-solving and new product development organization," Research Policy, Elsevier, vol. 34(9), pages 1305-1321, November.
  9. Loasby, Brian J., 2002. "The evolution of knowledge: beyond the biological model," Research Policy, Elsevier, vol. 31(8-9), pages 1227-1239, December.
  10. Christian Zeller, 2002. "Project Teams as Means of Restructuring Research and Development in the Pharmaceutical Industry," Regional Studies, Taylor & Francis Journals, vol. 36(3), pages 275-289.
  11. Udo Staber, 2010. "A Social-Evolutionary Perspective on Regional Clusters," Chapters, in: Ron Boschma & Ron Martin (ed.), The Handbook of Evolutionary Economic Geography, chapter 10, Edward Elgar Publishing.
  12. Blandinieres, Florence, 2019. "Anatomy of the medical innovation process: What are the consequences of replicability issues on innovation?," ZEW Discussion Papers 19-011, ZEW - Leibniz Centre for European Economic Research.
  13. Cooke, Phil, 2005. "Regionally asymmetric knowledge capabilities and open innovation: Exploring 'Globalisation 2'--A new model of industry organisation," Research Policy, Elsevier, vol. 34(8), pages 1128-1149, October.
  14. Jacqueline Senker, 2006. "Biotechnology Alliances in the European Pharmaceutical Industry: Past, Present and Future," SPRU Working Paper Series 137, SPRU - Science Policy Research Unit, University of Sussex Business School.
  15. Nicola Lacetera, 2003. "Incentives and spillovers in R&D activities: an agency-theoretic analysis of industry-university relations," Microeconomics 0312004, University Library of Munich, Germany.
  16. Julius Tan Gonzales, 2023. "Implications of AI innovation on economic growth: a panel data study," Journal of Economic Structures, Springer;Pan-Pacific Association of Input-Output Studies (PAPAIOS), vol. 12(1), pages 1-37, December.
  17. Paola Criscuolo & Rajneesh Narula, 2007. "Using multi-hub structures for international R&D: Organisational inertia and the challenges of implementation," Management International Review, Springer, vol. 47(5), pages 639-660, September.
  18. Hopkins, Michael M. & Martin, Paul A. & Nightingale, Paul & Kraft, Alison & Mahdi, Surya, 2007. "The myth of the biotech revolution: An assessment of technological, clinical and organisational change," Research Policy, Elsevier, vol. 36(4), pages 566-589, May.
  19. Criscuolo, Paola, 2005. "On the road again: Researcher mobility inside the R&D network," Research Policy, Elsevier, vol. 34(9), pages 1350-1365, November.
  20. Gilsing, Victor & Nooteboom, Bart, 2006. "Exploration and exploitation in innovation systems: The case of pharmaceutical biotechnology," Research Policy, Elsevier, vol. 35(1), pages 1-23, February.
  21. Yaqub, Ohid & Nightingale, Paul, 2012. "Vaccine innovation, translational research and the management of knowledge accumulation," Social Science & Medicine, Elsevier, vol. 75(12), pages 2143-2150.
  22. Taalbi, Josef, 2015. "Development Blocks in Innovation Networks. The Swedish Manufacturing Industry, 1970-2007," MPRA Paper 64549, University Library of Munich, Germany, revised 23 May 2015.
  23. Malo, Stéphane, 2009. "The contribution of (not so) public research to commercial innovations in the field of combinatorial chemistry," Research Policy, Elsevier, vol. 38(6), pages 957-970, July.
  24. Guerzoni, Marco & Taylor Aldridge, T. & Audretsch, David B. & Desai, Sameeksha, 2014. "A new industry creation and originality: Insight from the funding sources of university patents," Research Policy, Elsevier, vol. 43(10), pages 1697-1706.
  25. Josef Taalbi, 2017. "Development blocks in innovation networks," Journal of Evolutionary Economics, Springer, vol. 27(3), pages 461-501, July.
  26. Casper, Steven & Matraves, Catherine, 2003. "Institutional frameworks and innovation in the German and UK pharmaceutical industry," Research Policy, Elsevier, vol. 32(10), pages 1865-1879, December.
  27. Walrave, Bob & Gilsing, Victor A., 2023. "Game of skill or game of luck? Distant search in response to performance feedback," Technovation, Elsevier, vol. 121(C).
  28. Simeth, Markus & Lhuillery, Stephane, 2015. "How do firms develop capabilities for scientific disclosure?," Research Policy, Elsevier, vol. 44(7), pages 1283-1295.
  29. Engwall, Mats & Freilich, Jonatan, 2014. "Architectural Lock-in of the Drug Development Process," INDEK Working Paper Series 2014/4, Royal Institute of Technology, Department of Industrial Economics and Management.
  30. Siepel, Josh & Cowling, Marc & Coad, Alex, 2017. "Non-founder human capital and the long-run growth and survival of high-tech ventures," Technovation, Elsevier, vol. 59(C), pages 34-43.
  31. Jörg Mahlich, 2010. "Patents and performance in the Japanese pharmaceutical industry: An institution-based view," Asia Pacific Journal of Management, Springer, vol. 27(1), pages 99-113, March.
  32. Finn Valentin & Henrich Dahlgren & Rasmus Lund Jensen, 2006. "Research Strategies in Science-based Start-ups - Effects on performance in Danish and Swedish biotechnology," DRUID Working Papers 06-11, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies.
  33. Clara Calero & Thed N. Leeuwen & Robert J. W. Tijssen, 2007. "Research cooperation within the bio-pharmaceutical industry: Network analyses of co-publications within and between firms," Scientometrics, Springer;Akadémiai Kiadó, vol. 71(1), pages 87-99, April.
  34. Jiafeng Gu, 2021. "Determinants of biopharmaceutical R&D expenditures in China: the impact of spatiotemporal context," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(8), pages 6659-6680, August.
  35. Hopkins, Michael M. & Nightingale, Paul, 2006. "Strategic risk management using complementary assets: Organizational capabilities and the commercialization of human genetic testing in the UK," Research Policy, Elsevier, vol. 35(3), pages 355-374, April.
  36. Guerzoni, Marco & Aldridge, Taylor & Audretsch, David B & Sameeksha, Desai, 2012. "University Knowledge, Originality of Patents and the Creation of New Industries," Department of Economics and Statistics Cognetti de Martiis LEI & BRICK - Laboratory of Economics of Innovation "Franco Momigliano", Bureau of Research in Innovation, Complexity and Knowledge, Collegio 201219, University of Turin.
  37. Cohendet, Patrick & Meyer-Krahmer, Frieder, 2001. "The theoretical and policy implications of knowledge codification," Research Policy, Elsevier, vol. 30(9), pages 1563-1591, December.
  38. Haeussler, Carolin & Assmus, Anne, 2021. "Bridging the gap between invention and innovation: Increasing success rates in publicly and industry-funded clinical trials," Research Policy, Elsevier, vol. 50(2).
  39. Emmanuel Duguet & Stéphanie Monjon, 2004. "Is innovation persistent at the firm Level. An econometric examination comparing the propensity score and regression methods," Cahiers de la Maison des Sciences Economiques v04075, Université Panthéon-Sorbonne (Paris 1).
  40. Joao Mota & Luis M. de Castro, 2004. "A Capabilities Perspective on the Evolution of Firm Boundaries: A Comparative Case Example from the Portuguese Moulds Industry," Journal of Management Studies, Wiley Blackwell, vol. 41(2), pages 295-316, March.
  41. Mahlich, Jörg C. & Roediger-Schluga, Thomas, 2001. "The Changing Nature of Pharmaceutical R&D - Opportunities for Asia?," Research Memorandum 001, Maastricht University, Maastricht Economic Research Institute on Innovation and Technology (MERIT).
  42. Keith Pavitt, 2003. "The Process of Innovation," SPRU Working Paper Series 89, SPRU - Science Policy Research Unit, University of Sussex Business School.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.